Andreas Krebs - 21 Jun 2023 Form 4 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Role
Director
Signature
/s/ Robert Barrow, Attorney-in- Fact
Issuer symbol
MNMD
Transactions as of
21 Jun 2023
Net transactions value
$0
Form type
4
Filing time
23 Jun 2023, 17:52:20 UTC
Previous filing
06 Jun 2022
Next filing
12 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNMD Common Shares Award $0 +13,671 +952% $0.000000 15,107 21 Jun 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNMD Stock Option (Right to Buy) Award $0 +19,203 +182% $0.000000 29,748 21 Jun 2023 Common Shares 19,203 $3.61 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Common Share of the Issuer. The RSUs shall vest in four (4) equal quarterly installments from the grant date or upon the next Annual Meeting date, if earlier, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
F2 On August 26, 2022, the Issuer effected a 1-for-15 reverse stock split (the" Reverse Stock Split"). The number of securities reported on the Form 4 have been adjusted to reflect the Reverse Stock Split.
F3 The shares underlying the option shall vest in twelve (12) equal monthly installments starting from the grant date or upon the next Annual Meeting date, if earlier, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.